Accessible Product Design Alliance
The Accessible Product Design Alliance is a group of not-for-profit consumer health organisations that represent people with chronic conditions who are significantly impacted by inaccessible products and packaging. The Alliance was formed in 2019 to advocate to government and industry to improve access to products and packaging that are easy to use for these consumers and to increase research in the area.
The organisations that form the Alliance are Arthritis Australia, Arthritis New Zealand, Cerebral Palsy Alliance, Cystic Fibrosis Australia, Huntington’s Australia, MND Australia (Motor Neurone Disease), MS Australia (Multiple Sclerosis), Muscular Dystrophy Foundation of Australia, Parkinson’s Australia, Stroke Foundation of Australia and Pain Australia.
Products and packaging should be designed to be accessible for all consumers, regardless of their level of ability. Inaccessible products and packaging can cause day to day annoyance for people without disability, but for those who have a chronic condition or a disability these products and packaging can become impossible. Inaccessible products and packaging can cause unnecessary physical pain and discomfort, stress and frustration and impact a person’s independence. With the population ageing, and the increasing prevalence of people with chronic conditions and disability, accessible products and packaging should be at the forefront of design.
Keep up to date on the Alliance’s activities by following its new Instagram account www.instagram.com/accessiblealliance
Position Statement launch (14 September 2021) – click here to read the Position Statement and media release
To read more about the Accessible Product Design Alliance’s Vision and Objectives click here:
Discover more...
-
Arthritis Australia, Chronic Pain Australia and Consumers Health Forum of Australia Joint Statement ABC 4 Corners “Pain Factory” episode
Tuesday 9 April 2024 Last night’s episode of ABC 4 Corners highlighted the many adverse events people living with chronic musculoskeletal pain have experienced when...
-
Arthritis Australia welcomes funding for kids with arthritis
Arthritis Australia has welcomed Australian Government funding announced in the federal budget for kids living with juvenile arthritis, including renewed funding for Arthritis Australia and...
-
Shortage of Abatacept (Orencia®) – update
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has announced ashortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations of the medication....
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: